Science and Research

Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis

BACKGROUND: Radiomic features calculated from routine medical images show great potential for personalized medicine in cancer. Patients with systemic sclerosis (SSc), a rare, multi-organ autoimmune disorder, have a similarly poor prognosis due to interstitial lung disease (ILD). OBJECTIVES: To explore computed tomography (CT)-based high-dimensional image analysis (radiomics) for disease characterisation, risk stratification, and relaying information on lung pathophysiology in SSc-ILD. METHODS: We investigated two independent, prospectively followed SSc-ILD cohorts (Zurich, derivation cohort, n=90; Oslo, validation cohort, n=66). For every subject, we defined 1'355 robust radiomic features from standard-of-care CT images. We performed unsupervised clustering to identify and characterize imaging-based patient clusters. A clinically applicable prognostic quantitative radiomic risk score (qRISSc) for progression-free survival was derived from radiomic profiles using supervised analysis. The biological basis of qRISSc was assessed in a cross-species approach by correlation with lung proteomics, histological and gene expression data derived from mice with bleomycin-induced lung fibrosis. RESULTS: Radiomic profiling identified two clinically and prognostically distinct SSc-ILD patient clusters. To evaluate the clinical applicability, we derived and externally validated a binary, quantitative radiomic risk score composed of 26 features, qRISSc, that accurately predicted progression-free survival and significantly improved upon clinical risk stratification parameters in multivariable Cox regression analyses in the pooled cohorts. A high qRISSc score, which identifies patients at risk for progression, was reverse translatable from human to experimental ILD and correlated with fibrotic pathway activation. CONCLUSIONS: Radiomics-based risk stratification using routine CT images provides complementary phenotypic, clinical and prognostic information significantly impacting clinical decision-making in SSc-ILD.

  • Schniering, J.
  • Maciukiewicz, M.
  • Gabrys, H. S.
  • Brunner, M.
  • Blüthgen, C.
  • Meier, C.
  • Braga-Lagache, S.
  • Uldry, A. C.
  • Heller, M.
  • Guckenberger, M.
  • Fretheim, H.
  • Nakas, C. T.
  • Hoffmann-Vold, A. M.
  • Distler, O.
  • Frauenfelder, T.
  • Tanadini-Lang, S.
  • Maurer, B.
Publication details
DOI: 10.1183/13993003.04503-2020
Journal: Eur Respir J
Work Type: Original
Location: CPC-M
Disease Area: ROR, LC, PLI
Partner / Member: HMGU
Access-Number: 34649979

DZL Engagements

chevron-down